Completed PHASE1 INTERVENTIONAL 2-arm
NCT07119073
In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted) (Fed-Fast)
An Open-label, Randomized, Single-dose, Two-period, Two Treatment (Fed vs Fasted), Two Sequence, Crossover Study in Healthy Adult Subjects to Assess the Effect of Food on the Bioavailability of CTx-1301 (Dexmethylphenidate)
Sponsor: Cingulate Therapeutics
Conditions
Healthy Volunteers in Fed and Fasted State
Interventions
Dexmethylphenidate
Updated 1 time since 2025 Last updated: Aug 11, 2025 Started: Oct 31, 2024 Primary completion: Dec 21, 2024 Completion: Dec 27, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE1 clinical study on Healthy Volunteers in Fed and Fasted State, this trial is completed. The trial is conducted by Cingulate Therapeutics and has accumulated 1 data snapshot since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Completed — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Cingulate Therapeutics
Data source: Cingulate Therapeutics
For direct contact, visit the study record on ClinicalTrials.gov .